NN&I Researchers make step towards Kidney Regeneration

Researchers make step towards kidney regeneration by developing method for culturing kidney cells

Getty Images/Hemera/ThinkStock

Researchers have established methods for culturing kidney progenitor cells in vitro that maintain their ability to form the glomerulus. Researchers at Kumamoto University in Japan and the National Cancer Institute of the U.S. said the new findings, published in Cell Reports, represent a big step towards being able to regenerate kidneys.

The glomeruli and the tubules are generated from kidney progenitor cells during fetal life. These cells, however, are lost before or soon after birth when kidney development is completed. This is one of the major reasons why the kidney cannot be regenerated, the study authors said.

Read also: Cells collected from preterm infants’ urine may advance regenerative kidney repair

The method for inducing progenitor cells to make nephrons from human iPS cells was reported previously by Kumamoto University Professor Ryuichi Nishinakamura’s research group in 2013, but a large number of precursor cells are required for regenerative medicine. Many researchers have tried to culture kidney progenitor cells, but these cells could only be kept for two to three days at most.

“We isolated kidney progenitor cells from mice and searched for the most favorable culture conditions,” said Assistant Professor Shunsuke Tanigawa of Kumamoto University. Progenitor cells with a fluorescent green marker were isolated from mice, and culture conditions which preserved the marker, meaning that the cells were maintaining their function, were assessed. “The key was the use of the humoral  leukemia inhibitory factor (LIF). LIF is often used for ES cells and a special type of iPS cell. It is also known to accelerate kidney formation at the expense of progenitors. However, at low concentrations, it works in the opposite manner.”

Read also: Stem cell generated kidneys connect to blood vessels when transplanted into mice


The researchers then examined various combinations of humoral factors to determine the optimal culture conditions.

The optimized culture allowed kidney progenitor cells to retain their functionality (the ability to produce glomeruli and tubules) and grow up to 1,800 times their original amount over 20 days. In vivo, these cells disappear in about 10 days, but researchers using this method are now able to retain them for twice that amount of time. Additionally, the increase in the total amount of cells is approximately 100 times the amount normally found inside the body.

Further testing of this culture method on kidney progenitor cells derived from human iPS cells resulted in four times the total amount of cells over eight days. These cells also retained the potential to form glomeruli and tubules. This finding, a culture method that increases kidney progenitor cells while maintaining glomerulus-formation potential, is the first of its kind.

In regenerative medicine a large number of cells are required to construct an organ. The success of this research in determining a culture method that artificially increases both the amount of kidney progenitor cells and their viability time is a major development for the field, the researchers said. The finding is anticipated to help in the search for causes of kidney disease, new drug development, and other cellular research.

“If cryopreservation of these cultivated kidney progenitor cells is possible, we could omit the 14-day timespan that is required between iPS cell induction and progenitor cell creation and ultimately be able to supply them as research material,” Professor Nishinakamura said. “Our next target is to extend cell viability time and to find a more efficient culture method for cellular proliferation.”

Home Dialyzors United

Our Day, Our Way

Sign up and receive our latest updates!

With this information HDU can keep you informed of news and issues, including one quarterly Newsletter.

You may, of course, choose to opt out at any time by contacting HDU at HDUinfo@homedialyzorsunited.org.

Click Here to go directly to the website.

It has been Nichole Jefferson‘s personal mission to tell her story and promote awareness. She was diagnosed with end-stage renal disease (ESRD) in October 2003. At that time, not only was she unaware of what that meant; she also did not know she was a high-risk factor for developing the disease.
After the initial shock of the diagnosis, she decided peritoneal dialysis (PD) was the best option and utilized PD for a few years until she needed to switch to hemodialysis.
She received a kidney transplant from a deceased donor on June 12, 2008, but at the time, she didn’t realize it was simply another form of treatment and not a cure. Today, Nichole is waiting for a new transplant.
Nichole has worked with many advocacy groups on Capitol Hill and has provided her personal experience with ESRD to leaders in the field of nephrology. She tries to express the feelings of those who are unable or unwilling to speak for themselves.